Disclosure Policy and Disclosures
As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months.  All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations.  It is required that disclosure be provided to the learners prior to the start of the activity.  Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist.  Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.  Disclosure in no way implies that the information presented is biased or of lesser quality.  It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations.  Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.

The individuals listed below disclose the following financial relationships:

Matthew Greenhawt, MD – Speaker

Speaker: ACAAI, Aimmune, Allergy & Asthma Network, Before Brands, Canadian Society of Allergy & Clinical Immunology, DBV, EAACI, Eastern

Allergy Society, FL Society of Allergy & Immunology, Kansas City Allergy Society, Medscape, N. CA Allergy Society, Thermo Fisher

Advisory Board: Aimmune, Allergenis, Aquestive, DBV, Genentech, Intrommune, Kaléo, Monsanto, Nestlé, Nutricia, Prota, Sanofi/Genzyme

Consultant: Aimmune, Canadian Transportation Agency, Thermo Fisher

Principal Investigator: AHRQ, DBV BIOPOT

Employment: ACAAI, University of Colorado

Peter Lio, MD – Speaker

Speaker: Regeneron/Sanofi/Genzyme, Pierre-Fabre

Consultant: Regeneron/Sanofi/Genzyme, Abbvie, AOBiome, Eli Lilly, Galderma, Johnson & Johnson, L’Oreal, Theraplex (OTCs), Pierre-Fabre, Micreo (no U.S. product at this time)

Advisory Board: Regeneron/Sanofi/Genzyme, Abbvie, Derma Vant, Eli Lilly, Galderma, Johnson & Johnson, L’Oreal, Theraplex (OTCs), IntraDerm and Realm Therapeutics

Investigator: Regeneron/Sanofi/Genzyme, Abbvie, AOBiome

J. Allen Meadows, MD, FACAAI – Speaker

Speaker: Optinose, Pfizer, Teva

Advisory Board: GSK, Greer

Jordan S. Orange, MD, PhD – Speaker

Consultant: Shire, Grifols

Scientific Advisory Board: ADMA Biologics

Author/Editor: UpToDate

Reynold A. Panettieri, Jr., MD – Speaker

Consultant: AstraZeneca, MedImmune, RIFM, Equillium, Theravance, Boehringer-Ingelheim

Advisory Board: AstraZeneca, MedImmune, RIFM, Equillium, Theravance, Boehringer-Ingelheim

Research Grant: AstraZeneca, MedImmune, RIFM, Equillium, Teva

Speaker: AstraZeneca, Genentech, Sanofi-Regeneron

Madeline Ramos, MD – Presenter, Planner, Reviewer

Speaker: Teva

Raffi Tachdjian, MD – Planner

Speaker: Shire, Pharming, Regeneron/Sanofi, CSL Behring

Consultant: Shire, Pharming, Regeneron/Sanofi, CSL Behring

Clinical Trial: Shire, Biocryst

Sonal Patel, MD – Planner

Speaker: Sanofi/Regeneron, Pfizer

Steven Meltzer, MD, MBA – Planner

Investigator: Regeneron, AstraZeneca, Sanofi/Genzyme, Novartis, Pfizer

The following have no relevant financial relationships to disclose:

Linda Cox, MD – Speaker

David Edward Sloane, MD – Speaker

Barbara Weissman, MD – Speaker

Victoria Eng, MD – Speaker

Fernanda Delgado, MD – Speaker

Kevin Pedrotti – Speaker

Christina Schwindt, MD – Presenter, Planner

Robert Eitches, MD – Presenter, Planner, Reviewer

Marilyn Li, MD – Presenter, Planner

LanAnh Do, MD – Planner

Vincent Tubiolo, MD – Planner

Karol Anderson – Planner